Vasocor 2.5 mg (Tablet)
Unit Price: ৳ 7.00 (3 x 10: ৳ 210.00)
Strip Price: ৳ 70.00
Medicine Details
Category | Details |
---|---|
Generic | Nebivolol hydrochloride |
Company | Popular pharmaceuticals ltd |
Also available as |
Indications
- Hypertension
- Treatment of essential hypertension
- Chronic heart failure (CHF)
- Treatment of stable mild and moderate chronic heart failure in elderly patients.
Pharmacology
- β adrenergic receptor blocking agent
- Inhibits both β1 and β1 adrenergic receptors
- Lacks intrinsic sympathomimetic and membrane stabilizing activity
- Decreased heart rate
- Decreased myocardia contractility
- Diminution of tonic sympathetic outflow to the periphery from cerebral vasomotor centers
- Suppression of renin activity
- Vasodilation and decreased peripheral vascular resistance
- Metabolized by glucuronidation and hydroxylation by CYP2D6
- Mean peak plasma nebivolol concentrations occur approximately 1.5 to 4 hours post-dosing
- 98% human plasma protein binding to albumin
- Predominantly metabolized via direct glucuronidation of parent
- 38% of the dose recovered in urine and 44% in feces for EMs and 67% in urine and 13% in feces for PMs
Dosage & Administration
- Recommended starting dose is 5 mg once daily for most patients
- Dose can be increased at 2-week intervals up to 40 mg
- More frequent dosing regimen is unlikely to be beneficial
Interaction
- Use with care when myocardial depressants or inhibitors of AV conduction are used concurrently
- Contraindicated with other β-blockers
- Use caution when co-administered with CYP2D6 inhibitors (quinidine, propafenone, fluoxetine, paroxetine, etc.)
Contraindications
- Severe bradycardia
- Heart block greater than first degree
- Cardiogenic shock
- Decompensated cardiac failure
- Sick sinus syndrome (unless a permanent pacemaker is in place)
- Severe hepatic impairment (Child-Pugh >B)
- Hypersensitivity to any component of this product
Side Effects
- Headache
- Nausea
- Bradycardia
Precautions & Warnings
- Abrupt Cessation of Therapy
- Cardiac Failure
- Angina and Acute Myocardial Infarction
- Bronchospastic Diseases
- Anesthesia and Major Surgery
- Diabetes and Hypoglycemia
- Thyrotoxicosis
- Peripheral Vascular Disease
- Non-dihydropyridine Calcium Channel Blockers
Use in Special Populations
- Impaired Renal Function
- Impaired Hepatic Function
- Risk of Anaphylactic Reactions
Therapeutic Class
- Beta-adrenoceptor blocking drugs
- Beta-blockers
Storage Conditions
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.